TY - JOUR
T1 - Shprintzen-Goldberg syndrome
T2 - follow-up of the cardiovascular features in an international cohort of 29 patients with SGS
AU - Bouhatous, Yordi-Michaël
AU - Arnaud, Pauline
AU - Jondeau, Guillaume
AU - Bonneau, Dominique
AU - Rouleau, Frédéric
AU - Plessis, Ghislaine
AU - Vincent, Aline
AU - Labombarda, Fabien
AU - Maragnes, Pascale
AU - Delanne, Julian
AU - Muller, Matthias
AU - Coubes, Christine
AU - Bredy, Charlene
AU - Gouya, Laurent
AU - Odent, Sylvie
AU - Basquin, Adeline
AU - Dupuis-Girod, Sophie
AU - Barthelet, Martine
AU - Ginglinger, Emmanuelle
AU - Delobel, Bruno
AU - Vaksmann, Guy
AU - Alessandri, Jean-Luc
AU - Arsac, Louis André
AU - Thomas, Edouard
AU - Julia, Sophie
AU - Chesneau, Bertrand
AU - Dulac, Yves
AU - Callewaert, Bert
AU - Loeys, Bart
AU - Vaerle, Maxim
AU - Menke, Leonie A.
AU - Groenink, Maarten
AU - Ades, Lesley
AU - Ballesta-Martinez, Maria Juliana
AU - Shanske, Alan L.
AU - Tinschert, Sigrid
AU - Gehle, Petra
AU - Thauvin-Robinet, Christel
AU - Eicher, Jean-Christophe
AU - Falcon-Eicher, Sylvie
AU - Boileau, Catherine
AU - Binquet, Christine
AU - Hanna, Nadine
AU - Faivre, Laurence
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.
PY - 2025/9/1
Y1 - 2025/9/1
N2 - Background: Shprintzen-Goldberg syndrome (SGS) shares skeletal features with Marfan syndrome (MFS), but differs in its craniofacial and neurodevelopmental features. Cardiovascular features have been specifically investigated in few of the 57 known patients with SGS described in the literature, making it difficult to determine their prevalence and characteristics. Methods: We reviewed the medical records of an international cohort of 29 patients, with a particular focus on cardiovascular features. Data were compared with those of MFS. Results: The sex ratio was 1.9 and median age was 23 years (range: 4-54). 13 patients (44.8%) had mitral regurgitation (MR), 11 (37.9%) had a thoracic aortic aneurysm (TAA) and 9 (31.1%) had aortic regurgitation (AR). No cases of aortic dissection were reported. None had beta-blockers as a primary prevention of aortic events. The Kaplan-Meier method revealed a 30 years risk of 47%, 33% and 22% for occurrence of MR, TAA and AR, respectively. A statistically significant association was found between variants in the Dachshund Homology Domain and the risk of aortic aneurysm (11/20 vs 0/9, p=0.036). Conclusion: Patients with SGS also significantly have cardiovascular manifestations, encouraging the implementation of a follow-up and preventive cardiovascular treatment identical to that of MFS.
AB - Background: Shprintzen-Goldberg syndrome (SGS) shares skeletal features with Marfan syndrome (MFS), but differs in its craniofacial and neurodevelopmental features. Cardiovascular features have been specifically investigated in few of the 57 known patients with SGS described in the literature, making it difficult to determine their prevalence and characteristics. Methods: We reviewed the medical records of an international cohort of 29 patients, with a particular focus on cardiovascular features. Data were compared with those of MFS. Results: The sex ratio was 1.9 and median age was 23 years (range: 4-54). 13 patients (44.8%) had mitral regurgitation (MR), 11 (37.9%) had a thoracic aortic aneurysm (TAA) and 9 (31.1%) had aortic regurgitation (AR). No cases of aortic dissection were reported. None had beta-blockers as a primary prevention of aortic events. The Kaplan-Meier method revealed a 30 years risk of 47%, 33% and 22% for occurrence of MR, TAA and AR, respectively. A statistically significant association was found between variants in the Dachshund Homology Domain and the risk of aortic aneurysm (11/20 vs 0/9, p=0.036). Conclusion: Patients with SGS also significantly have cardiovascular manifestations, encouraging the implementation of a follow-up and preventive cardiovascular treatment identical to that of MFS.
KW - Aneurysm
KW - Arrhythmias, Cardiac
KW - Genetic Diseases, Inborn
KW - Vascular Diseases
UR - https://www.scopus.com/pages/publications/105009741246
U2 - 10.1136/jmg-2024-110341
DO - 10.1136/jmg-2024-110341
M3 - Article
C2 - 40562530
SN - 0022-2593
VL - 62
SP - 600
EP - 606
JO - Journal of medical genetics
JF - Journal of medical genetics
IS - 9
ER -